Yahoo Search Busca da Web

Resultado da Busca

  1. Há 3 dias · This educational activity is designed to meet the needs of physicians, nurses, and other clinical professionals who manage patients with cancer. NCCN, drawing on the expertise of faculty from its 21 member institutions, has developed and maintains clinical practice guidelines addressing colon and rectal cancers as part of its complete library ...

  2. Há 2 dias · All 42 patients with locally advanced mismatch repair-deficient (dMMR) rectal cancer had a clinical complete response following treatment with dostarlimab-gxly (Jemperli), according to data from a phase 2 trial (NCT04165772) presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting.1. Additionally, with median follow-up ...

  3. Há 3 dias · The goal of this activity is to describe common symptoms among survivors of colorectal cancer and the management of these patients. Upon completion of this activity, participants will be able to: Analyze the prognosis of colorectal cancer (CRC) Identify the most common symptom among survivors of CRC. Distinguish emotional concerns among ...

  4. Há 18 horas · Background Colorectal cancer (CRC) is a malignant tumor within the digestive tract with both a high incidence rate and mortality. Early detection and intervention could improve patient clinical outcomes and survival. Methods This study computationally investigates a set of prognostic tissue and cell features from diagnostic tissue slides. With the combination of clinical prognostic variables ...

  5. Há 2 dias · Colorectal cancer ( CRC ), also known as bowel cancer, colon cancer, or rectal cancer, is the development of cancer from the colon or rectum (parts of the large intestine ). [5] Signs and symptoms may include blood in the stool, a change in bowel movements, weight loss, abdominal pain and fatigue. [9] Most colorectal cancers are due to old age ...

  6. Há 18 horas · Zebrafish patient-derived xenograft models (zAvatar) can be used to study cancer biology as well as to predict patient clinical outcomes and response to therapies. Here, in a cohort of 55 patients ...

  7. Há 2 dias · Dostarlimab-gxly (Jemperli) elicited a clinical complete response (cCR) in all 42 patients with locally advanced mismatch repair–deficient (dMMR) rectal cancer who completed treatment with the ...